In 2025, the Singapore-MIT Alliance for Research and Technology (SMART) has reinforced its position at the forefront of scientific innovation. Our interdisciplinary research groups (IRGs) have continued to focus on tackling critical challenges in antimicrobial resistance, disease management, cell therapy development, global food security, and the proliferation of AI and emerging technologies. With the launch of two new IRGs, Wafer-scale Integrated Sensing Devices based on Opt

The Wearable Imaging for Transforming Elderly Care (WITEC) collaborative research project aims to develop the world’s first wearable ultrasound imaging system for continuous, real-time monitoring and personalised diagnosis of chronic conditions such as hypertension and heart failure. WITEC is a multi-million dollar, multi-year initiative that brings together top researchers from the Massachusetts Institute of Technology, Nanyang Technological University and the National Unive

Singapore faces a critical challenge with rising chronic diseases, especially among the ageing population and individuals with multiple long-term conditions, which demands a new approach to elderly care that current technologies simply can't provide.  What if we could move beyond simple wellness tracking and unlock technologies that can provide real-time monitoring and personalised diagnosis? Imagine ultrasound imaging that can be done at home, or even on the move, continuous

On 5 November, the CREATE Seminar ‘Intelligence with Resilience: AI, Robotics, and Security at the Frontiers’, brought together four leading CREATE entities — Singapore-HUJ Alliance for Research and Enterprise (SHARE), Imperial Global Singapore (IGS), Illinois Advanced Research Center at Singapore (Illinois ARCS), and the Mens, Manus, and Machina (M3S) interdisciplinary group from Singapore-MIT Alliance for Research Technology (SMART) — to showcase complementary strengths in

The Mens Manus Machina (M3S)  interdisciplinary research group at the Singapore-MIT Alliance for Research and Technology (SMART) is on a mission to revolutionise the future of artificial intelligence (AI) and robotics. From advanced solutions to intelligent systems, M3S researchers are creating technologies that make work safer, smarter, and more sustainable. One of the brilliant minds driving this innovation is Professor Cecilia Laschi, Principal Investigator at SMART M3S. H

A groundbreaking discovery reveals a unique way phages modify their DNA with arabinose sugars to protect themselves from bacterial defence systems This innovative discovery could lead to more effective phage therapy to combat antibiotic-resistant bacteria, including Acinetobacter baumannii – a   WHO-classified critical priority pathogen responsible for life-threatening infections The research discovered that natural DNA phage modifications occur at a higher rate than previous

The Antimicrobial Resistance (AMR) interdisciplinary research group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART) aims to develop innovative and disruptive approaches to tackle one of today’s most pressing health threats – antimicrobial resistance.  One of the researchers driving this mission is May Delos Santos, Principal Research Engineer at SMART AMR. Through her research, May aims to advance the understanding of antimicrobial resistance and devel

Singapore, 13 October 2025 - The dairy industry has been plagued by a persistent global problem for decades – bacterial infection of cow...

Dr Kerwin Kwek Zeming, Research Scientist at SMART CAMP, recently presented CAMP’s latest work at the Cell & Gene Therapy World Asia 2025 conference, where he shared insights from the team’s research paper on label-free, microfluidic-based biophysical profiling of Chimeric Antigen Receptor T (CAR T) cells.   Through his presentation, Dr Kwek showcased CAMP’s efforts to develop advanced tools for the next generation of cell therapies. “We developed a microfluidic ‘obstacle cou

In August 2025, SMART’s Critical Analytics for Manufacturing Personalized-Medicine (CAMP) interdisciplinary research group (IRG) hosted an Adoptive Cell Therapy Symposium, co-organised with Esco Aster, a Singapore-founded and headquartered vertically-integrated contract research, development and manufacturing organisation. The half-day event brought together a diverse community of cell therapy manufacturing researchers, clinician-scientists, biotech innovators, investors, and